We've encountered safety issues with incorrect dosing/monitoring of vancomycin and aminoglycosides in peritoneal dialysis solutions, and are exploring options to improve the safety of our process. For example, a patient receiving vancomycin daily versus intermittently based on levels. Unfamiliarity with PD dosing and infrequent use are contributing factors we've identified. How does your institution handle these orders safely to ensure accurate dosing/monitoring?
- Do you incorporate pharmacy consults? How is that operationalized?
- Any other strategies that have been employed?
Look forward to learning from you!